These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 8675285)

  • 1. Evaluation of purified UspA from Moraxella catarrhalis as a vaccine in a murine model after active immunization.
    Chen D; McMichael JC; VanDerMeid KR; Hahn D; Mininni T; Cowell J; Eldridge J
    Infect Immun; 1996 Jun; 64(6):1900-5. PubMed ID: 8675285
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A major outer membrane protein of Moraxella catarrhalis is a target for antibodies that enhance pulmonary clearance of the pathogen in an animal model.
    Helminen ME; Maciver I; Latimer JL; Cope LD; McCracken GH; Hansen EJ
    Infect Immun; 1993 May; 61(5):2003-10. PubMed ID: 7683000
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exploration of Moraxella catarrhalis outer membrane proteins, CD and UspA, as new carriers for lipooligosaccharide-based conjugates.
    Hu WG; Berry J; Chen J; Gu XX
    FEMS Immunol Med Microbiol; 2004 Jun; 41(2):109-15. PubMed ID: 15145454
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhancement of clearance of bacteria from murine lungs by immunization with detoxified lipooligosaccharide from Moraxella catarrhalis conjugated to proteins.
    Hu WG; Chen J; Battey JF; Gu XX
    Infect Immun; 2000 Sep; 68(9):4980-5. PubMed ID: 10948114
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mapping Protective Regions on a Three-Dimensional Model of the Moraxella catarrhalis Vaccine Antigen Oligopeptide Permease A.
    Perez AC; Johnson A; Chen Z; Wilding GE; Malkowski MG; Murphy TF
    Infect Immun; 2018 Mar; 86(3):. PubMed ID: 29203544
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Investigating the potential of conserved inner core oligosaccharide regions of Moraxella catarrhalis lipopolysaccharide as vaccine antigens: accessibility and functional activity of monoclonal antibodies and glycoconjugate derived sera.
    Cox AD; St Michael F; Cairns CM; Lacelle S; Filion AL; Neelamegan D; Wenzel CQ; Horan H; Richards JC
    Glycoconj J; 2011 May; 28(3-4):165-82. PubMed ID: 21590368
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A large, antigenically conserved protein on the surface of Moraxella catarrhalis is a target for protective antibodies.
    Helminen ME; Maciver I; Latimer JL; Klesney-Tait J; Cope LD; Paris M; McCracken GH; Hansen EJ
    J Infect Dis; 1994 Oct; 170(4):867-72. PubMed ID: 7523537
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isolation and characterization of two proteins from Moraxella catarrhalis that bear a common epitope.
    McMichael JC; Fiske MJ; Fredenburg RA; Chakravarti DN; VanDerMeid KR; Barniak V; Caplan J; Bortell E; Baker S; Arumugham R; Chen D
    Infect Immun; 1998 Sep; 66(9):4374-81. PubMed ID: 9712790
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mapping of a protective epitope of the CopB outer membrane protein of Moraxella catarrhalis.
    Aebi C; Cope LD; Latimer JL; Thomas SE; Slaughter CA; McCracken GH; Hansen EJ
    Infect Immun; 1998 Feb; 66(2):540-8. PubMed ID: 9453607
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Moraxella catarrhalis outer membrane protein CD elicits antibodies that inhibit CD binding to human mucin and enhance pulmonary clearance of M. catarrhalis in a mouse model.
    Liu DF; McMichael JC; Baker SM
    Infect Immun; 2007 Jun; 75(6):2818-25. PubMed ID: 17403868
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional characteristics of a protective monoclonal antibody against serotype A and C lipooligosaccharides from Moraxella catarrhalis.
    Hu WG; Chen J; McMichael JC; Gu XX
    Infect Immun; 2001 Mar; 69(3):1358-63. PubMed ID: 11179299
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of an isogenic mutant constructed in Moraxella catarrhalis To identify a protective epitope of outer membrane protein B1 defined by monoclonal antibody 11C6.
    Luke NR; Russo TA; Luther N; Campagnari AA
    Infect Immun; 1999 Feb; 67(2):681-7. PubMed ID: 9916077
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The transferrin binding protein B of Moraxella catarrhalis elicits bactericidal antibodies and is a potential vaccine antigen.
    Myers LE; Yang YP; Du RP; Wang Q; Harkness RE; Schryvers AB; Klein MH; Loosmore SM
    Infect Immun; 1998 Sep; 66(9):4183-92. PubMed ID: 9712766
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A protective epitope of Moraxella catarrhalis is encoded by two different genes.
    Aebi C; Maciver I; Latimer JL; Cope LD; Stevens MK; Thomas SE; McCracken GH; Hansen EJ
    Infect Immun; 1997 Nov; 65(11):4367-77. PubMed ID: 9353007
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutant lipooligosaccharide-based conjugate vaccine demonstrates a broad-spectrum effectiveness against Moraxella catarrhalis.
    Ren D; Yu S; Gao S; Peng D; Petralia RS; Muszynski A; Carlson RW; Robbins JB; Tsai CM; Lim DJ; Gu XX
    Vaccine; 2011 Jun; 29(25):4210-7. PubMed ID: 21501641
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunological characterisation of truncated lipooligosaccharide-outer membrane protein based conjugate vaccine against Moraxella catarrhalis and nontypeable Haemophilus influenzae.
    Singh S; Wilson JC; Cripps AW; Massa H; Ozberk V; Grice ID; Peak IR
    Vaccine; 2020 Jan; 38(2):309-317. PubMed ID: 31668366
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The major outer membrane protein, CD, extracted from Moraxella (Branhamella) catarrhalis is a potential vaccine antigen that induces bactericidal antibodies.
    Yang YP; Myers LE; McGuinness U; Chong P; Kwok Y; Klein MH; Harkness RE
    FEMS Immunol Med Microbiol; 1997 Mar; 17(3):187-99. PubMed ID: 9093840
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comprehensive antigen screening identifies Moraxella catarrhalis proteins that induce protection in a mouse pulmonary clearance model.
    Smidt M; Bättig P; Verhaegh SJ; Niebisch A; Hanner M; Selak S; Schüler W; Morfeldt E; Hellberg C; Nagy E; Lundberg U; Hays JP; Meinke A; Henriques-Normark B
    PLoS One; 2013; 8(5):e64422. PubMed ID: 23671716
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune responses to specific antigens of Streptococcus pneumoniae and Moraxella catarrhalis in the respiratory tract.
    Samukawa T; Yamanaka N; Hollingshead S; Klingman K; Faden H
    Infect Immun; 2000 Mar; 68(3):1569-73. PubMed ID: 10678976
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of a 74-kDa transferrin-binding protein from Moraxella (Branhamella) catarrhalis as a vaccine candidate.
    Chen D; McMichael JC; VanDerMeid KR; Masi AW; Bortell E; Caplan JD; Chakravarti DN; Barniak VL
    Vaccine; 1999 Aug; 18(1-2):109-18. PubMed ID: 10501241
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.